Utility of plasma tumour necrosis factor-alpha and transforming growth factor-beta1 as predictors of survival and treatment outcome in advanced non-small cell lung carcinoma.

@article{Kumar2010UtilityOP,
  title={Utility of plasma tumour necrosis factor-alpha and transforming growth factor-beta1 as predictors of survival and treatment outcome in advanced non-small cell lung carcinoma.},
  author={Sachin Kumar and Randeep Guleria and Anant Mohan and Vikas Singh and Ashraf Ali and Alok Chandra Bharti and Bhudev Chandra Das},
  journal={Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals},
  year={2010},
  volume={15 5},
  pages={446-53}
}
We hypothesized that plasma level of tumour necrosis factor (TNF)-alpha and transforming growth factor (TGF)-beta1 may be a potential tool for diagnosis, prognosis and prediction of treatment outcome in non-small cell lung carcinoma (NSCLC). Plasma levels of TNF-alpha and TGF-beta1 were quantified in 100 NSCLC patients and 100 controls. Association of TNF… CONTINUE READING